Compounds in development to combat hyperphosphataemia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.12, 2001-12, pp. : 2185-2190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sevelamer could be worth it in hyperphosphataemia

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

ESRD with hyperphosphataemia: an economic burden

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 505, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Sevelamer could be worth it in hyperphosphataemia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 552, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective

By Gonzáález Mercedes Cerecetto Hugo

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 5, 2011-05 ,pp. : 699-715

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Development of Antifungal Compounds

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 27-71

Bentham Science Publishers

Access to resources Recommend Favorite